Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Marotta, A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(11)
+
-
Availability
Metadata Only
(11)
+
-
Creation Date
2014
(4)
+
-
2012
(3)
+
-
2011
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(11)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(11)
+
-
Topic
RHEUMATOID ARTHRITIS
(2)
+
-
Author
Heijde, D. van der
(11)
+
-
Landewe, R.
(11)
+
-
Marotta, A.
(11)
+
-
Maksymowych, W.P.
(10)
+
-
Boers, M.
(7)
+
-
Schaardenburg, D. van
(6)
+
-
Tak, P.P.
(6)
+
-
Bykerk, V.P.
(5)
+
-
Siminovitch, K.A.
(5)
+
-
Boire, G.
(4)
+
-
Bykerk, V.
(3)
+
-
Murphy, M.
(3)
+
-
Allaart, C.F.
(2)
+
-
Britsemmer, K.
(2)
+
-
Genovese, M.C.
(2)
+
-
Keystone, E.
(2)
+
-
Keystone, E.C.
(2)
+
-
Kuijk, A.W. van
(2)
+
-
Turk, S.
(2)
+
-
Weinblatt, M.E.
(2)
+
-
Show more
Language
en
(11)
+
-
Search results
(1 - 11 of 11)
show grid
show list
save search
14-3-3 eta Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis
14-3-3 eta is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage
Serum 14-3-3 eta is a Novel Marker that Complements Current Serological Measurements to Enhance Detection of Patients with Rheumatoid Arthritis
Citrullinated 14-3-3 eta Antibodies Are Specific for Early and Established RA and Are Complementary to ACPA
Serum 14-3-3 eta is an RA Specific Diagnostic Marker that Predicts RA Development in Arthralgia Patients
91% Of Early RA Patients Are Positive For Serum 14-3-3 eta Or Its Auto-Antibodies
14-3-3 Eta Is a Novel Citrullination Target in Rheumatoid Arthritis That Enhances Diagnostic Utility in Anti-CCP Negative Patients
Validation of Prognostic Biomarkers for RA: Testing of 14-3-3 Eta According to the Omeract Soluble Biomarker Criteria
Novel Autoantibodies to 14-3-3 Eta Are Highly Specific for Rheumatoid Arthritis
Serum 14-3-3 eta: A Rheumatoid Arthritis Biomarker
Extracellular 14-3-3 eta: An Early Rheumatoid Arthritis Pathogenic Factor